MedPath

Measurement of certain vitamin and metal nutrient and an enzyme level; that is; thiamine pyrophosphate, copper and phosphodiestrase; in blood; in individuals having and not having diabetis related eye disease; and comparing them with their vision test report.

Not Applicable
Conditions
Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications
Registration Number
CTRI/2021/12/038793
Lead Sponsor
PG grant KMC Manipal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Group A) individuals 40-75yrs age and both genders; without having diabetes mellitus.

Group B) individuals 40-75yrs age and both genders, diagnosed with diabetes mellitus and havenâ??t developed any retinal complication.

Group C) individuals 40-75yrs age and both genders, with diabetes mellitus and diagnosed with non proliferative diabetic retinopathy.

Group D) individuals 40-75yrs age and both genders, with diabetes mellitus and diagnosed with proliferative diabetic retinopathy.

Exclusion Criteria

i. individuals with other retinal conditions

ii. individuals undergone recent surgery or recent blood transfusion ( <3months)

iii. individuals having other comorbid diseases like malignancies, severe systemic illness

iv. chronic alcoholics

v. anaemic patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum thiamine pyrophosphate, copper, phosphodiesterase (PDE) among all the participants.Timepoint: baseline
Secondary Outcome Measures
NameTimeMethod
Visual acuity scores and diabetic retinopathy grading as per the modified ETDRS criteria among patients with DRTimepoint: baseline and 3 months (post LASER / anti VEGEF treatment among those patients with retinopathy undergoing treatment).
© Copyright 2025. All Rights Reserved by MedPath